Registro:

Referencias:

• Melo, R.C.N., Acute heart inflammation: ultrastructural and functional aspects of macrophages elicited by Trypanosoma cruzi infection (2009) J Cell Mol Med, 13, pp. 279-294
• Petray, P., Castaños-Velez, E., Grinstein, S., Orn, A., Rottenberg, M.E., Role of nitric oxide in resistance and histopathology during experimental infection with Trypanosoma cruzi (1995) Immunol Lett, 47, pp. 121-126
• Petray, P., Rottenberg, M.E., Grinstein, S., Orn, A., Release of nitric oxide during the experimental infection with Trypanosoma cruzi (1994) Parasite Immunol, 16, pp. 193-199
• Muñoz-Fernández, M.A., Fernández, M.A., Fresno, M., Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism (1992) Eur J Immunol, 22, pp. 301-307
• Silva, J.S., Vespa, G.N.R., Cardoso, M.A.G., Aliberti, J.C.S., Cunha, F.Q., Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages (1995) Infect Immun, 63, pp. 4862-4867
• Abrahamsohn, I.A., Coffman, R.L., Trypanosoma cruzi: IL-10, TNF, IFN-γ, and IL-12 regulate innate and acquired immunity to infection (1996) Exp Parasitol, 84, pp. 231-244
• Chandrasekar, B., Melby, P.C., Troyer, D.A., Colston, J.T., Freeman, G.L., Temporal expression of pro-inflammatory cytokines and inducible nitric oxide synthase in experimental acute chagasic cardiomyopathy (1998) Am J Pathol, 152, pp. 925-934
• Souza, P.E.A., Rocha, M.O.C., Rocha-Vieira, E., Menezes, C.A.S., Chaves, A.C.L., Gollob, K.J., Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity (2004) Infect Immun, 72, pp. 5283-5291
• Keating, S.M., Deng, X., Fernandes, F., Cunha-Neto, E., Ribeiro, A.L., Adesina, B., Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease (2015) Int J Cardiol, 199, pp. 451-459
• Gomes, J.A.S., Bahia-Oliveira, L.M.G., Rocha, M.O.C., Martins-Filho, O.A., Gazzinelli, G., Correa-Oliveira, R., Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response (2003) Infect Immun, 71, pp. 1185-1193
• Cunha-Neto, E., Chevillard, C., Chagas disease cardiomyopathy: immunopathology and genetics (2014) Mediators Inflamm, 2014, p. 11
• Rassi, A., Jr., Rassi, A., Marin-Neto, J.A., Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification (2009) Mem Inst Oswaldo Cruz, 104, pp. 152-158
• Eltzschig, H.K., Carmeliet, P., Carmeliet, P., Hypoxia and inflammation (2011) N Engl J Med, 364, pp. 656-665
• Konisti, S., Kiriakidis, S., Paleolog, E.M., Hypoxia-a key regulator of angiogenesis and inflammation in rheumatoid arthritis (2012) Nat Rev Rheumatol, 8, pp. 153-162
• Costa, C., Incio, J., Soares, R., Angiogenesis and chronic inflammation: cause or consequence? (2007) Angiogenesis, 10, pp. 149-166
• Kotlinowski, J., Grochot-Przeczek, A., Taha, H., Kozakowska, M., Pilecki, B., Skrzypek, K., PPAR γ activation but not PPAR γ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors (2014) Cardiovasc Diabetol, 13, p. 150
• Biscetti, F., Gaetani, E., Flex, A., Aprahamian, T., Hopkins, T., Straface, G., Selective activation of peroxisome induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism (2008) Diabetes, 57, pp. 1394-1404
• Yue, T.L., Chen, J., Bao, W., Narayanan, P.K., Bril, A., Jiang, W., In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone (2001) Circulation, 104, pp. 2588-2594
• Yamakawa, K., Hosoi, M., Koyama, H., Tanaka, S., Fukumoto, S., Morii, H., Peroxisome proliferator-activated receptor-α agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells (2000) Biochem Biophys Res Commun, 271, pp. 571-574
• Fujii, M., Inoki, I., Saga, M., Morikawa, N., Arakawa, K., Inaba, S., Aldosterone inhibits endothelial morphogenesis and angiogenesis through the downregulation of vascular endothelial growth factor receptor-2 expression subsequent to peroxisome proliferator-activated receptor gamma (2012) J Steroid Biochem Mol Biol, 129, pp. 145-152
• Bishop-Bailey, D., PPARs and angiogenesis (2011) Biochem Soc Trans, 39, pp. 1601-1605
• Brun, P., Dean, A., Di Marco, V., Surajit, P., Castagliuolo, I., Carta, D., Peroxisome proliferator-activated receptor-γ mediates the anti-inflammatory effect of 3-hydroxy-4-pyridinecarboxylic acid derivatives: synthesis and biological evaluation (2013) Eur J Med Chem, 62, pp. 486-497
• Mirkin, G.A., Jones, M., Sanz, O.P., Rey, R., Sica, R.E., González Cappa, S.M., Experimental Chagas' disease: electrophysiology and cell composition of the neuromyopathic inflammatory lesions in mice infected with a myotropic and a pantropic strain of Trypanosoma cruzi (1994) Clin Immunol Immunopathol, 73, pp. 69-79
• Humphrey, W., Dalke, A., Schulten, K., VMD: visual molecular dynamics (1996) J Mol Graph, 14, pp. 33-38 and 27-28
• Brun, P., Dean, A., Di, V., Surajit, P., Castagliuolo, I., Carta, D., Peroxisome proliferator-activated receptor-g mediates the anti-inflammatory effect of 3-hydroxy-4-pyridinecarboxylic acid derivatives: synthesis and biological evaluation (2013) Eur J Med Chem, 62, pp. 486-497
• Sali, A., Blundell, T.L., Comparative protein modelling by satisfaction of spatial restraints (1993) J Mol Biol, 234, pp. 779-815
• Milburn, M.V., Nolte, R.T., Wisely, G.B., Westin, S., Cobb, J.E., Lambert, M.H., Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma (1998) Nature, 395, pp. 137-143
• Morris, G.M., Huey, R., Lindstrom, W., Sanner, M.F., Belew, R.K., Goodsell, D.S., AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility (2009) J Comput Chem, 30, pp. 2785-2791
• Modenutti, C., Gauto, D., Radusky, L., Blanco, J., Turjanski, A., Hajos, S., Using crystallographic water properties for the analysis and prediction of lectin-carbohydrate complex structures (2015) Glycobiology, 25, pp. 181-196
• Penas, F., Mirkin, G.A., Vera, M., Cevey, Á., González, C.D., Gómez, M.I., Treatment in vitro with PPARa and PPARγ ligands drives M1-to-M2 polarization of macrophages from T. cruzi-infected mice (2015) Biochim Biophys Acta, 1852, pp. 893-904
• Goren, N., Cuenca, J., Martin Sanz, P., Bosca, L., Attenuation of NF-kappaB signalling in rat cardiomyocytes at birth restricts the induction of inflammatory genes (2004) Cardiovasc Res, 64, pp. 289-297
• de la Torre, E., Davel, L., Jasnis, M.A., Gotoh, T., de Lustig, E.S., Sales, M.E., Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice (2005) Breast Cancer Res, 7, pp. 345-352
• de la Torre, E., Hovsepian, E., Penas, F.N., Dmytrenko, G., Castro, M.E., Goren, N.B., Macrophages derived from septic mice modulate nitric oxide synthase and angiogenic mediators in the heart (2013) J Cell Physiol, 228, pp. 1584-1593
• Penas, F.N., Cevey, Á.C., Siffo, S., Mirkin, G.A., Goren, N.B., Hepatic injury associated with Trypanosoma cruzi infection is attenuated by treatment with 15-deoxy-γ12,14 prostaglandin J2 (2016) Exp Parasitol, 170, pp. 100-108
• Hovsepian, E., Penas, F., Siffo, S., Mirkin, G.A., Goren, N.B., IL-10 inhibits the NF-κB and ERK/MAPK-mediated production of pro-inflammatory mediators by up-regulation of SOCS-3 in Trypanosoma cruzi-infected cardiomyocytes (2013) PLoS One, 8
• Kruger, N.J., The Bradford method for protein quantitation (1994) Methods Mol Biol, 32, pp. 9-15
• Hovsepian, E., Mirkin, G.A., Penas, F., Manzano, A., Bartrons, R., Goren, N.B., Modulation of inflammatory response and parasitism by 15-Deoxy-γ(12,14) prostaglandin J(2) in Trypanosoma cruzi-infected cardiomyocytes (2011) Int J Parasitol, 41, pp. 553-562
• Penas, F., Mirkin, G.A., Hovsepian, E., Cevey, Á., Caccuri, R., Sales, M.E., PPARγ ligand treatment inhibits cardiac inflammatory mediators induced by infection with different lethality strains of Trypanosoma cruzi (2013) Biochim Biophys Acta Mol Basis Dis, 1832, pp. 239-248
• Escudero, C.A., Herlitz, K., Troncoso, F., Guevara, K., Acurio, J., Aguayo, C., Pro-angiogenic role of insulin: from physiology to pathology (2017) Front Physiol, 8, p. 204
• Liao, H.H., Jia, X.H., Liu, H.J., Yang, Z., Tang, Q.Z., The role of PPARs in pathological cardiac hypertrophy and heart failure (2017) Curr Pharm Des, 23, pp. 1677-1686
• Abou Daya, K., Abu Daya, H., Nasser Eddine, M., Nahhas, G., Nuwayri-Salti, N., Effects of rosiglitazone (PPARγ agonist) on the myocardium in non-hypertensive diabetic rats (2015) J Diabetes, 7, pp. 85-94
• Zhao, S.-M., Li, H.-W., Guo, C.-Y., Shen, L.-H., Cardiac fibrosis in diabetic rats: regulation and mechanism of activation of the PPARgamma signal pathway (2010) Chin J Physiol, 53, pp. 262-267
• Hu, Q., Chen, J., Jiang, C., Liu, H.-F., Effect of peroxisome proliferator-activated receptor gamma agonist on heart of rabbits with acute myocardial ischemia/reperfusion injury (2014) Asian Pac J Trop Med, 7, pp. 271-275
• Itoh, T., Fairall, L., Amin, K., Inaba, Y., Szanto, A., Balint, B.L., Structural basis for the activation of PPARgamma by oxidized fatty acids (2008) Nat Struct Mol Biol, 15, pp. 924-931
• Egawa, D., Itoh, T., Yamamoto, K., Characterization of covalent bond formation between PPARγ and oxo-fatty acids (2015) Bioconjug Chem, 26, pp. 690-698
• Assunção, L.S., Magalhães, K.G., Carneiro, A.B., Molinaro, R., Almeida, P.E., Atella, G.C., Schistosomal-derived lysophosphatidylcholine triggers M2 polarization of macrophages through PPARγ dependent mechanisms (2017) Biochim Biophys Acta, 1862, pp. 246-254
• Odegaard, J.I., Ricardo-Gonzalez, R.R., Goforth, M.H., Morel, C.R., Subramanian, V., Mukundan, L., Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance (2007) Nature, 447, pp. 1116-1120
• Scholz, A., Plate, K.H., Reiss, Y., Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation (2015) Ann N Y Acad Sci, 1347, pp. 45-51
• Guedes-da-Silva, F.H., Shrestha, D., Salles, B.C., Figueiredo, V.P., Lopes, L.R., Dias, L., Trypanosoma cruzi antigens induce inflammatory angiogenesis in a mouse subcutaneous sponge model (2015) Microvasc Res, 97, pp. 130-136
• Shrestha, D., Bajracharya, B., Paula-Costa, G., Salles, B.C., Leite, A.L.J., Menezes, A.P.J., Expression and production of cardiac angiogenic mediators depend on the Trypanosoma cruzi-genetic population in experimental C57BL/6 mice infection (2017) Microvasc Res, 110, pp. 56-63
• Ashoff, A., Qadri, F., Eggers, R., Jöhren, O., Raasch, W., Dendorfer, A., Pioglitazone prevents capillary rarefaction in streptozotocin-diabetic rats independently of glucose control and vascular endothelial growth factor expression (2012) J Vasc Res, 49, pp. 260-266
• Zhang, H., Wei, T., Jiang, X., Li, Z., Cui, H., PEDF and 34-mer inhibit angiogenesis in the heart by inducing tip cells apoptosis via up-regulating PPAR-c to increase surface FasL (2016) Apoptosis, 21, pp. 60-68
• Funovics, P., Brostjan, C., Nigisch, A., Fila, A., Grochot, A., Mleczko, K., Effects of 15d-PGJ(2) on VEGF-induced angiogenic activities and expression of VEGF receptors in endothelial cells (2006) Prostaglandins Other Lipid Mediat, 79, pp. 230-244
• Kim, K.Y., Ahn, J.H., Cheon, H.G., Anti-angiogenic action of PPARγ ligand in human umbilical vein endothelial cells is mediated by PTEN upregulation and VEGFR-2 downregulation (2011) Mol Cell Biochem, 358, pp. 375-385
• Tanowitz, H.B., Machado, F.S., Spray, D.C., Friedman, J.M., Oren, S., Lora, J.N., Developments in the management of Chagas cardiomyopathy (2016) Expert Rev Cardiovasc Ther, 13, pp. 1393-1409
• Koitabashi, N., Arai, M., Kogure, S., Niwano, K., Watanabe, A., Aoki, Y., Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis (2007) Hypertension, 49 (5), pp. 1120-1127

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------